Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis
N Engl J Med
.
2024 Mar 21;390(12):1154.
doi: 10.1056/NEJMc2401126.
Authors
Zhenjie Chen
1
,
Jiajia Bai
2
,
Liwen Niu
2
Affiliations
1
Beijing University of Chinese Medicine, Beijing, China ruoshui8000@126.com.
2
Hohhot Hospital of Traditional Chinese Medicine and Mongolian Medicine, Hohhot, China.
PMID:
38507768
DOI:
10.1056/NEJMc2401126
No abstract available
Publication types
Letter
Comment
MeSH terms
Glomerulosclerosis, Focal Segmental* / drug therapy
Humans
Irbesartan / therapeutic use
Spiro Compounds*
Sulfonamides
Substances
Irbesartan
sparsentan
Spiro Compounds
Sulfonamides